Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-part Study Investigating the Effect of the X39 Patch on Circulating Blood Levels of GHK and GHK-Cu in a Healthy Adult Population

NCT07706361 is registered in ClinicalTrials.gov with LifeWave, Inc. as lead sponsor.

NCT NCT07706361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07706361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-part Study Investigating the Effect of the X39 Patch on Circulating Blood Levels of GHK and GHK-Cu in a Healthy Adult Population
Lead sponsor
LifeWave, Inc.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 31, 2027
Completion date
April 30, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ghk and ghk-cu blood levels